Green Cross Medical Science Corporation

KOSDAQ:A142280 Stock Report

Market Cap: ₩77.4b

Green Cross Medical Science Past Earnings Performance

Past criteria checks 2/6

Green Cross Medical Science has been growing earnings at an average annual rate of 12.9%, while the Medical Equipment industry saw earnings growing at 18.7% annually. Revenues have been growing at an average rate of 0.7% per year. Green Cross Medical Science's return on equity is 0.3%, and it has net margins of 0.2%.

Key information

12.9%

Earnings growth rate

27.2%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate0.7%
Return on equity0.3%
Net Margin0.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Mar 26
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

Recent updates

Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?

Aug 30
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?

There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise

Aug 08
There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise

We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Mar 26
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Feb 24
These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Jan 28
Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Jan 02
Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

Dec 07
Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

Revenue & Expenses Breakdown

How Green Cross Medical Science makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A142280 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2499,7161508,3293,305
30 Jun 2496,2911,1768,5583,050
31 Mar 2494,3071,0938,6332,751
31 Dec 2394,0111,7978,5032,880
30 Sep 2397,968-1,47012,0392,780
30 Jun 2398,8901,18512,6462,772
31 Mar 2392,65194510,1172,595
31 Dec 22113,109-3,58111,2052,167
30 Sep 2297,543-19,9479,9522,015
30 Jun 2299,135-26,73213,6981,982
31 Mar 22122,852-25,19218,4252,037
31 Dec 21101,675-21,20218,6082,134
30 Sep 21122,7292,28517,6732,407
30 Jun 21126,5365,72414,8262,508
31 Mar 21114,4687,32813,0442,691
31 Dec 20113,3776,55411,9482,654
30 Sep 20103,0771,6869,9402,504
30 Jun 2091,8975179,1522,390
31 Mar 2084,430-9,5929,0312,196
31 Dec 1981,493-11,2269,3202,188
30 Sep 1981,306-13,4479,9022,066
30 Jun 1984,003-15,65910,3972,102
31 Mar 1985,913-10,19410,6732,087
31 Dec 1886,322-10,71111,2822,058
30 Sep 1888,457-9,27612,1201,960
30 Jun 1892,921-6,39412,5301,790
31 Mar 1894,750-3,99512,6691,777
31 Dec 1798,389-1,34812,3791,818
30 Sep 1795,79561312,5701,884
30 Jun 1790,728-23611,9251,994
31 Mar 1788,887-89911,6131,888
31 Dec 1686,163-1,89111,6921,653
30 Sep 1686,656-2,70110,5831,589
30 Jun 1689,432-1,27710,7071,438
31 Mar 1689,028-2110,3731,238
31 Dec 1589,2987299,8861,146
30 Sep 1588,0522,9359,753975
31 Dec 1481,3353,7178,7721,018

Quality Earnings: A142280 has a large one-off loss of ₩1.2B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: A142280 became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A142280 has become profitable over the past 5 years, growing earnings by 12.9% per year.

Accelerating Growth: A142280 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A142280 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-13.3%).

Return on Equity

High ROE: A142280's Return on Equity (0.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:33
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Green Cross Medical Science Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiyong LeeShinhan Investment Corp.